Recombinant Viruses for Cancer Therapy

 Recombinant viruses area unit novel therapeutic agents that may be utilized for treatment of assorted diseases, as well as cancers. Recombinant viruses will be designed to precise foreign transgenes and have a broad reaction permitting organic phenomenon in an exceedingly wide selection of host cells. They can be designed for specific therapeutic goals. The recombinant viruses can be customizes to stimulate host response against tumor-specific antigens so that it can overcome the ability of the tumor to evade the host’s immune surveillance. Alternatively, recombinant viruses might categorical immunomodulatory genes that stimulate associate anti-cancer immune reaction

    Related Conference of Recombinant Viruses for Cancer Therapy

    August 22-23, 2022

    Global Congress on Pancreas

    Budapest, Hungary
    August 29-30, 2022

    45th International Conference on Gastroenterology

    Osaka, Japan
    September 19-20, 2022

    24th World Congress on Advances in Gastroenterology, Hepatology & Endoscopy

    Singapore City, Singapore
    November 14-15, 2022

    13th International Conference on Liver Diseases & Hepatology

    Amsterdam, Netherlands
    November 28-29, 2022

    World Conference on Digestive and metabolic diseases

    Kyoto, Japan
    December 07-08, 2022

    45th World Strock Summit

    Prague, Czech Republic
    December 19-20, 2022

    2nd World Conference on Gastroenterology and Digestive Diseases

    Amsterdam, Netherlands
    January 30-31, 2023

    18th Euro-Global Gastroenterology Conference

    Barcelona, Spain
    July 18-19, 2023

    2nd International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    August 23-24, 2023

    29th World Conference on Gastroenterology & Hepatology

    Toronto, Canada
    August 30-31, 2023

    22st World Congress on Gastrointestinal Cancer

    Dublin, Ireland

    Recombinant Viruses for Cancer Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in